Skip to content
2000
Volume 2, Issue 2
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Cordycepin (3;-deoxyadenosine) is a potent anti-leukemic, anti-fungal, and anti-parasitic nucleoside antibiotic. Unfortunately, the biological activity of cordycepin is attenuated by its rapid conversion to 3;-deoxyinosine by adenosine deaminase (ADA). We have synthesized a series of ADA-resistant N-aminal and N-thioaminal cordycepin derivatives, which are protected from inactivation by deamination and yet retain biological activity. These compounds are hydrolyzed at various rates to efficiently release the parent drug cordycepin, and likely serve as simple hydrolytically activated prodrugs.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180053175151
2005-03-01
2025-05-30
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180053175151
Loading

  • Article Type:
    Review Article
Keyword(s): adenosine deaminase; cordycepin; leukemia; prodrug
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test